CELL INTELLIGENCE · 肿瘤细胞治疗研究

胶质母细胞瘤的下一代治疗：挑战与未来方向

Next-generation therapeutics for glioblastoma: Challenges and future directions.

H3 K27 变异型弥漫性中线胶质瘤时代的弥漫性内生性脑桥胶质瘤

Diffuse intrinsic pontine glioma in the era of H3 K27-altered diffuse midline glioma.

装甲 CAR-T 细胞抗耗竭：胶质母细胞瘤的工程化策略

Armoring CAR-T Cells Against Exhaustion: Engineering Strategies for Glioblastoma.

推进胶质母细胞瘤 CAR-T 细胞疗法前沿：从临床障碍到突破性策略的现状探索

Advancing chimeric antigen receptor T-cell therapy frontiers in glioblastoma: Navigating the current landscape from clinical hurdles to breakthrough s

克服胶质母细胞瘤免疫治疗耐药：既往经验与未来机遇

Overcoming resistance in glioblastoma immunotherapy: lessons from the past and opportunities for the future.

重新认识胶质母细胞瘤免疫治疗：克服多维耐药的四大支柱框架

Reconceptualizing glioblastoma immunotherapy: a four-pillar framework to overcome multidimensional resistance.

溶瘤病毒增强 CAR-T 活性用于治疗儿童弥漫性中线胶质瘤

Oncolytic viruses enhance CAR-T activity for the treatment of pediatric diffuse midline gliomas.

儿童恶性脑肿瘤中全身性与颅内免疫治疗递送：一项系统综述、荟萃分析和 meta 回归

Systemic versus intracranial immunotherapy delivery in pediatric malignant brain tumors: a systematic review, meta-analysis, and meta-regression.

免疫治疗的给药途径似乎不影响生存结局。

打破胶质母细胞瘤的免疫隔离

Breaking immune isolation in glioblastoma.

胶质瘤治疗中免疫治疗的现状与演变

Current Status and Evolution of Immunotherapy in Glioma Management.